Skip to main content

Peer Review reports

From: Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial

Original Submission
27 Sep 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 Nov 2021 Reviewed Reviewer Report
5 Dec 2021 Reviewed Reviewer Report
9 Dec 2021 Author responded Author comments - Ching-Chan Lin
Resubmission - Version 3
9 Dec 2021 Submitted Manuscript version 3
25 Dec 2021 Author responded Author comments - Ching-Chan Lin
Resubmission - Version 4
25 Dec 2021 Submitted Manuscript version 4
14 Jan 2022 Reviewed Reviewer Report
28 Jan 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
31 Jan 2022 Editorially accepted
15 Feb 2022 Article published 10.1186/s12885-022-09258-0

You can find further information about peer review here.

Back to article page